Cybin Gears Up for Global Phase 3 Depression Trial

Cybin (TSE:CYBN) has released an update. Cybin Inc., a clinical-stage neuropsychiatry company, is poised to launch a global Phase 3 pivotal...
23 hours ago
from: TipRanks

Business Wire, Health care, Pharmaceutical industry

More about this

- Cybin Expands Clinical Team to Support CYB003 Phase 3 Program
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed...
from: Business Wire

- Cybin gears up for Phase 3 trial in depression treatment
TORONTO - Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN), a clinical-stage biopharmaceutical company, announced the expansion of its...
from: Investing.com